Chilman, Natasha
Laporte, Dionne
Dorrington, Sarah
Hatch, Stephani L.
Morgan, Craig
Okoroji, Celestin
Stewart, Robert
Das-Munshi, Jayati
Funding for this research was provided by:
Economic and Social Research Council
National Institute for Health and Care Research
South London and Maudsley NHS Foundation Trust
UK Research and Innovation
Health Foundation, United Kingdom
Academy of Medical Sciences
Article History
Received: 6 May 2023
Accepted: 11 January 2024
First Online: 20 February 2024
Declarations
:
: RS declares research support received in the last 36 months from Janssen, GSK and Takeda. CM is the Editor-in-Chief of Social Psychiatry and Psychiatric Epidemiology. All other authors have no competing interests to declare that are relevant to the content of this article.
: The SLaM Case Register has been approved as a source of de-identified data for secondary analyses (Oxford Research Ethics Committee C, reference 18/SC/0372). This approval was extended in 2023 (reference 23/SC/0257). The study protocol was reviewed and approved by the patient-led CRIS oversight committee (reference: 21–051).